Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso—Implications for introduction of PsA-TT into the Expanded Programme on Immunization

BACKGROUND: A new serogroup A meningococcal conjugate vaccine (PsA-TT, MenAfriVac™) has been developed to combat devastating serogroup A Neisseria meningitis (MenA) epidemics in Africa. A mass immunization campaign targeting 1–29 year olds was conducted in Burkina Faso in December 2010. Protection o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Vaccine
Autori principali: Meyer, Sarah A., Kambou, Jean Ludovic, Cohn, Amanda, Goodson, James L., Flannery, Brendan, Medah, Isaïe, Messonnier, Nancy, Novak, Ryan, Diomande, Fabien, Djingarey, Mamoudou H., Clark, Thomas A., Yameogo, Issaka, Fall, Amadou, Wannemuehler, Kathleen
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5755366/
https://ncbi.nlm.nih.gov/pubmed/25636915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.01.043
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi